Evidence map›Paper›PMID 23333623›Full record

ReviewFEBS letters2013

Phospholipid--driven gene regulation.

Paul M Musille, Jeffrey A Kohn, Eric A Ortlund

Open access · hybridAbstract readReview
In one paragraph

Review in FEBS letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Phospholipid regulation of the nuclear receptor superfamily.Advances in biological regulation · 2017
    Review
  18. Article
  19. Article
  20. The systematic analysis of protein-lipid interactions comes of age.Nature reviews. Molecular cell biology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paul M MusilleDepartment of Biochemistry, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Jeffrey A Kohn
Eric A Ortlund
Emory University · US

Funding

Targeting LRH-1 - Phospholipid Signaling in Metabolic PathwaysR01DK095750 · NIDDK · EMORY UNIVERSITY · PI ORTLUND, ERIC A · 2012 to 2016
$1.7M
NIDDK NIH HHS R01 DK095750
6 · The paper itself

Abstract

Phospholipids (PLs), well known for their fundamental role in cellular structure, play critical signaling roles via their derivatives and cleavage products acting as second messengers in signaling cascades. Recent work has shown that intact PLs act as signaling molecules in their own right by modulating the activity of nuclear hormone transcription factors responsible for tuning genes involved in metabolism, lipid flux, steroid synthesis and inflammation. As such, PLs have been classified as novel hormones. This review highlights recent work in PL-driven gene regulation with a focus on the unique structural features of phospholipid-sensing transcription factors and what sets them apart from well known soluble phospholipid transporters.

Indexed as

Gene Expression RegulationSignal TransductionHumansModels, GeneticModels, MolecularMolecular StructurePhospholipidsProtein BindingProtein Structure, TertiaryTranscription FactorsPhospholipidsTranscription Factors

Identifiers

PMID23333623
PMCPMC3632008
OpenAlexW2014240035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.